NCT06898957
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06898957
Title Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC) ((DeLLphi-310))
Acronym (DeLLphi-310)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | HUN | GRC | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
City of Hope Orange County Lennar Foundation Cancer Center Irvine California 92618 United States Details
Yale New Haven Hospital New Haven Connecticut 06510 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Siteman Cancer Center St Louis Missouri 63110 United States Details
Sanford Roger Maris Cancer Center Fargo North Dakota 58122 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Sanford Oncology Clinic and Pharmacy Sioux Falls South Dakota 54104 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Swedish Medical Center Seattle Washington 98104 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
CHU de Quebec Hopital de l Enfant Jesus Québec Quebec G1J 1Z4 Canada Details
Shandong Cancer Hospital Jinan Shandong 250117 China Details
West China Hospital of Sichuan University Chengdu Sichuan 611135 China Details
Fujian Cancer Hospital Fuzhou 350011 China Details
Institut Bergonie Bordeaux 33000 France Details
Centre Leon Berard Lyon 69373 France Details
Institut Universitaire du Cancer Toulouse Oncopole Toulouse 31059 France Details
Gustave Roussy Villejuif 94805 France Details
Universitaetsklinikum Essen Essen 45147 Germany Details
Henry Dunant Hospital Center Athens 11526 Greece Details
Alexandra Hospital Athens 11528 Greece Details
European Interbalkan Medical Center Thessaloniki 57001 Greece Details
Iatriko Diavalkaniko Thessalonikis Thessaloniki 57001 Greece Details
Semmelweis Egyetem Budapest 1083 Hungary Details
Clinexpert Kft Bugat Pal Korhaz Gyöngyös 3200 Hungary Details
Istituto di Candiolo Fondazione del Piemonte per l Oncologia IRCCS Candiolo to 10060 Italy Details
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori Meldola (FC) 47014 Italy Details
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda Milan 20162 Italy Details
Seoul National University Hospital Seoul 03080 South Korea Details
Severance Hospital Yonsei University Health System Seoul 03722 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Hospital Universitari Vall d Hebron Barcelona Catalonia 08035 Spain Details
Hospital de la Santa Creu i Sant Pau Barcelona Catalonia 08041 Spain Details
Hospital Universitario Puerta de Hierro Majadahonda Majadahonda Madrid 28222 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field